WAM
IONS icon

Weiss Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Weiss Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,874
Closed -$297K – 400
2023
Q4 		$297K Buy
+5,874
New +$281K 0.01% 276
2022
Q2 		– Sell
-18,145
Closed -$672K – 717
2022
Q1 		$672K Buy
+18,145
New +$594K 0.01% 601
2018
Q4 		– Sell
-17,983
Closed -$928K – 467
2018
Q3 		$928K Hold
17,983
– – 0.07% 104
2018
Q2 		$749K Hold
17,983
– – 0.07% 104
2018
Q1 		$793K Hold
17,983
– – 0.06% 99
2017
Q4 		$905K Buy
17,983
+8,358
+87% +$458K 0.08% 88
2017
Q3 		$488K Buy
+9,625
New +$504K 0.05% 70

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weiss Asset Management's IONS Position: Q1 2024 in Review

Weiss Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 5,874 shares — an estimated $297K sold.

Weiss Asset Management first reported a position in IONS in Q3 2017 and held it in 7 quarters. The position peaked at $928K in Q3 2018. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Weiss Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Weiss Asset Management sold 5,874 Ionis Pharmaceuticals shares in Q1 2024, an estimated $297K.
  • Weiss Asset Management first reported a position in Ionis Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Weiss Asset Management's Ionis Pharmaceuticals position peaked at $928K in Q3 2018.
  • 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Weiss Asset Management's 13F filing for Q1 2024, filed 13 May 2024.